Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon
Search Study Connect

Researching Lung Cancer

Lung cancer starts when cells of the lung become abnormal and begin to grow out of control

Lung Cancer Clinical Trials

Lung Cancer Clinical Trials

We are investigating experimental medications for both Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC)

Non-small cell lung cancer (NSCLC)  accounts for about 85–90% of Lung Cancer diagnoses, while Small cell lung cancer (SCLC) is composed of 10-15% of Lung Cancer diagnoses. These two types of cancer differ in how they grow and how they spread.

Answer a few questions below to see if there are clinical trials that might be right for you. 

What is Immunotherapy?

What is Immunotherapy? 3:29

What is Immunotherapy?

Learn how activating your immune system with immuno-oncology treatments may be able to help fight cancer.

Thank you for Considering a Clinical Trial

Below you will find  clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).

Here are some options for you to find more information:

  1. Browse the trials available on your own and Click on View Trial Details for more information, including locations that are recruiting patients.
    - or -
  2. Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you. 

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

What are you thankful for?

Explore Lung Cancer Resources

Quick Guide – Approaches to Cancer Therapy in Clinical Research

Quick Guide – Approaches to Cancer Therapy in Clinical Research

Immuno-oncology is a newer area of research that seeks to help the body’s own immune system fight cancer. Much of our ongoing research is being done to see if an immuno-oncology investigational treatment can be compared to or used together with standard of care treatments
Learn More

Lung Cancer by the Numbers

Lung cancer has been the most common cancer in the world for several decades, and despite advancements in treatment, has resulted in more deaths than any other cancer.
Learn More

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Email Us

Have questions?
Email Us